GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization. - Mahadevan A; Vosooghi A; Arora JS; Kumar RS; Singh G; Tsai KK; Quandt Z (The Journal of clinical endocrinology and metabolism, 2026)